Transdermal Patch-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data
Report Summary
Transdermal Patch-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data offers a comprehensive analysis on Transdermal Patch industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Transdermal Patch 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Transdermal Patch worldwide and market share by regions, with company and product introduction, position in the Transdermal Patch market
Market status and development trend of Transdermal Patch by types and applications
Cost and profit status of Transdermal Patch, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Transdermal Patch market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Transdermal Patch industry.
The report segments the global Transdermal Patch market as:
Global Transdermal Patch Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Transdermal Patch Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Methyl Salicylate-Based Patch
Rivastigmine Patch
Fentanyl Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Patch
Others
Global Transdermal Patch Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Rx Channel
OTC Channel
Global Transdermal Patch Market: Manufacturers Segment Analysis (Company and Product introduction, Transdermal Patch Sales Volume, Revenue, Price and Gross Margin):
Hisamitsu Pharmaceutical
Gr?nenthal
UCB Pharma
Johnson & Johnson
Nitto Denko
Novartis
GSK
Teva Pharmaceutical
Mylan
IBSA Group
Bayer
Beijing Tide Pharmaceutical
Luye Pharma Group
Mundipharma
Dr Reddy’s Laboratories
Pfizer
Endo International
Chattem
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Transdermal Patch-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data offers a comprehensive analysis on Transdermal Patch industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Transdermal Patch 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Transdermal Patch worldwide and market share by regions, with company and product introduction, position in the Transdermal Patch market
Market status and development trend of Transdermal Patch by types and applications
Cost and profit status of Transdermal Patch, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Transdermal Patch market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Transdermal Patch industry.
The report segments the global Transdermal Patch market as:
Global Transdermal Patch Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Transdermal Patch Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Methyl Salicylate-Based Patch
Rivastigmine Patch
Fentanyl Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Patch
Others
Global Transdermal Patch Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Rx Channel
OTC Channel
Global Transdermal Patch Market: Manufacturers Segment Analysis (Company and Product introduction, Transdermal Patch Sales Volume, Revenue, Price and Gross Margin):
Hisamitsu Pharmaceutical
Gr?nenthal
UCB Pharma
Johnson & Johnson
Nitto Denko
Novartis
GSK
Teva Pharmaceutical
Mylan
IBSA Group
Bayer
Beijing Tide Pharmaceutical
Luye Pharma Group
Mundipharma
Dr Reddy’s Laboratories
Pfizer
Endo International
Chattem
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF TRANSDERMAL PATCH
1.1 Definition of Transdermal Patch in This Report
1.2 Commercial Types of Transdermal Patch
1.2.1 Methyl Salicylate-Based Patch
1.2.2 Rivastigmine Patch
1.2.3 Fentanyl Patch
1.2.4 Lidocaine Patch
1.2.5 Diclofenac Patch
1.2.6 Nicotine Patch
1.2.7 Others
1.3 Downstream Application of Transdermal Patch
1.3.1 Rx Channel
1.3.2 OTC Channel
1.4 Development History of Transdermal Patch
1.5 Market Status and Trend of Transdermal Patch 2015-2026
1.5.1 Global Transdermal Patch Market Status and Trend 2015-2026
1.5.2 Regional Transdermal Patch Market Status and Trend 2015-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Transdermal Patch 2015-2019
2.2 Sales Market of Transdermal Patch by Regions
2.2.1 Sales Volume of Transdermal Patch by Regions
2.2.2 Sales Value of Transdermal Patch by Regions
2.3 Production Market of Transdermal Patch by Regions
2.4 Global Market Forecast of Transdermal Patch 2020-2026
2.4.1 Global Market Forecast of Transdermal Patch 2020-2026
2.4.2 Market Forecast of Transdermal Patch by Regions 2020-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Transdermal Patch by Types
3.2 Sales Value of Transdermal Patch by Types
3.3 Market Forecast of Transdermal Patch by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Transdermal Patch by Downstream Industry
4.2 Global Market Forecast of Transdermal Patch by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Transdermal Patch Market Status by Countries
5.1.1 North America Transdermal Patch Sales by Countries (2015-2019)
5.1.2 North America Transdermal Patch Revenue by Countries (2015-2019)
5.1.3 United States Transdermal Patch Market Status (2015-2019)
5.1.4 Canada Transdermal Patch Market Status (2015-2019)
5.1.5 Mexico Transdermal Patch Market Status (2015-2019)
5.2 North America Transdermal Patch Market Status by Manufacturers
5.3 North America Transdermal Patch Market Status by Type (2015-2019)
5.3.1 North America Transdermal Patch Sales by Type (2015-2019)
5.3.2 North America Transdermal Patch Revenue by Type (2015-2019)
5.4 North America Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Transdermal Patch Market Status by Countries
6.1.1 Europe Transdermal Patch Sales by Countries (2015-2019)
6.1.2 Europe Transdermal Patch Revenue by Countries (2015-2019)
6.1.3 Germany Transdermal Patch Market Status (2015-2019)
6.1.4 UK Transdermal Patch Market Status (2015-2019)
6.1.5 France Transdermal Patch Market Status (2015-2019)
6.1.6 Italy Transdermal Patch Market Status (2015-2019)
6.1.7 Russia Transdermal Patch Market Status (2015-2019)
6.1.8 Spain Transdermal Patch Market Status (2015-2019)
6.1.9 Benelux Transdermal Patch Market Status (2015-2019)
6.2 Europe Transdermal Patch Market Status by Manufacturers
6.3 Europe Transdermal Patch Market Status by Type (2015-2019)
6.3.1 Europe Transdermal Patch Sales by Type (2015-2019)
6.3.2 Europe Transdermal Patch Revenue by Type (2015-2019)
6.4 Europe Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Transdermal Patch Market Status by Countries
7.1.1 Asia Pacific Transdermal Patch Sales by Countries (2015-2019)
7.1.2 Asia Pacific Transdermal Patch Revenue by Countries (2015-2019)
7.1.3 China Transdermal Patch Market Status (2015-2019)
7.1.4 Japan Transdermal Patch Market Status (2015-2019)
7.1.5 India Transdermal Patch Market Status (2015-2019)
7.1.6 Southeast Asia Transdermal Patch Market Status (2015-2019)
7.1.7 Australia Transdermal Patch Market Status (2015-2019)
7.2 Asia Pacific Transdermal Patch Market Status by Manufacturers
7.3 Asia Pacific Transdermal Patch Market Status by Type (2015-2019)
7.3.1 Asia Pacific Transdermal Patch Sales by Type (2015-2019)
7.3.2 Asia Pacific Transdermal Patch Revenue by Type (2015-2019)
7.4 Asia Pacific Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Transdermal Patch Market Status by Countries
8.1.1 Latin America Transdermal Patch Sales by Countries (2015-2019)
8.1.2 Latin America Transdermal Patch Revenue by Countries (2015-2019)
8.1.3 Brazil Transdermal Patch Market Status (2015-2019)
8.1.4 Argentina Transdermal Patch Market Status (2015-2019)
8.1.5 Colombia Transdermal Patch Market Status (2015-2019)
8.2 Latin America Transdermal Patch Market Status by Manufacturers
8.3 Latin America Transdermal Patch Market Status by Type (2015-2019)
8.3.1 Latin America Transdermal Patch Sales by Type (2015-2019)
8.3.2 Latin America Transdermal Patch Revenue by Type (2015-2019)
8.4 Latin America Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Transdermal Patch Market Status by Countries
9.1.1 Middle East and Africa Transdermal Patch Sales by Countries (2015-2019)
9.1.2 Middle East and Africa Transdermal Patch Revenue by Countries (2015-2019)
9.1.3 Middle East Transdermal Patch Market Status (2015-2019)
9.1.4 Africa Transdermal Patch Market Status (2015-2019)
9.2 Middle East and Africa Transdermal Patch Market Status by Manufacturers
9.3 Middle East and Africa Transdermal Patch Market Status by Type (2015-2019)
9.3.1 Middle East and Africa Transdermal Patch Sales by Type (2015-2019)
9.3.2 Middle East and Africa Transdermal Patch Revenue by Type (2015-2019)
9.4 Middle East and Africa Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL PATCH
10.1 Global Economy Situation and Trend Overview
10.2 Transdermal Patch Downstream Industry Situation and Trend Overview
CHAPTER 11 TRANSDERMAL PATCH MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Transdermal Patch by Major Manufacturers
11.2 Production Value of Transdermal Patch by Major Manufacturers
11.3 Basic Information of Transdermal Patch by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Transdermal Patch Major Manufacturer
11.3.2 Employees and Revenue Level of Transdermal Patch Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 TRANSDERMAL PATCH MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Hisamitsu Pharmaceutical
12.1.1 Company profile
12.1.2 Representative Transdermal Patch Product
12.1.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
12.2 Gr?nenthal
12.2.1 Company profile
12.2.2 Representative Transdermal Patch Product
12.2.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Gr?nenthal
12.3 UCB Pharma
12.3.1 Company profile
12.3.2 Representative Transdermal Patch Product
12.3.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of UCB Pharma
12.4 Johnson & Johnson
12.4.1 Company profile
12.4.2 Representative Transdermal Patch Product
12.4.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.5 Nitto Denko
12.5.1 Company profile
12.5.2 Representative Transdermal Patch Product
12.5.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Nitto Denko
12.6 Novartis
12.6.1 Company profile
12.6.2 Representative Transdermal Patch Product
12.6.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Novartis
12.7 GSK
12.7.1 Company profile
12.7.2 Representative Transdermal Patch Product
12.7.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of GSK
12.8 Teva Pharmaceutical
12.8.1 Company profile
12.8.2 Representative Transdermal Patch Product
12.8.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
12.9 Mylan
12.9.1 Company profile
12.9.2 Representative Transdermal Patch Product
12.9.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mylan
12.10 IBSA Group
12.10.1 Company profile
12.10.2 Representative Transdermal Patch Product
12.10.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of IBSA Group
12.11 Bayer
12.11.1 Company profile
12.11.2 Representative Transdermal Patch Product
12.11.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Bayer
12.12 Beijing Tide Pharmaceutical
12.12.1 Company profile
12.12.2 Representative Transdermal Patch Product
12.12.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Beijing Tide Pharmaceutical
12.13 Luye Pharma Group
12.13.1 Company profile
12.13.2 Representative Transdermal Patch Product
12.13.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Luye Pharma Group
12.14 Mundipharma
12.14.1 Company profile
12.14.2 Representative Transdermal Patch Product
12.14.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mundipharma
12.15 Dr Reddy’s Laboratories
12.15.1 Company profile
12.15.2 Representative Transdermal Patch Product
12.15.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Dr Reddy’s Laboratories
12.16 Pfizer
12.17 Endo International
12.18 Chattem
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL PATCH
13.1 Industry Chain of Transdermal Patch
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL PATCH
14.1 Cost Structure Analysis of Transdermal Patch
14.2 Raw Materials Cost Analysis of Transdermal Patch
14.3 Labor Cost Analysis of Transdermal Patch
14.4 Manufacturing Expenses Analysis of Transdermal Patch
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Transdermal Patch in This Report
1.2 Commercial Types of Transdermal Patch
1.2.1 Methyl Salicylate-Based Patch
1.2.2 Rivastigmine Patch
1.2.3 Fentanyl Patch
1.2.4 Lidocaine Patch
1.2.5 Diclofenac Patch
1.2.6 Nicotine Patch
1.2.7 Others
1.3 Downstream Application of Transdermal Patch
1.3.1 Rx Channel
1.3.2 OTC Channel
1.4 Development History of Transdermal Patch
1.5 Market Status and Trend of Transdermal Patch 2015-2026
1.5.1 Global Transdermal Patch Market Status and Trend 2015-2026
1.5.2 Regional Transdermal Patch Market Status and Trend 2015-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Transdermal Patch 2015-2019
2.2 Sales Market of Transdermal Patch by Regions
2.2.1 Sales Volume of Transdermal Patch by Regions
2.2.2 Sales Value of Transdermal Patch by Regions
2.3 Production Market of Transdermal Patch by Regions
2.4 Global Market Forecast of Transdermal Patch 2020-2026
2.4.1 Global Market Forecast of Transdermal Patch 2020-2026
2.4.2 Market Forecast of Transdermal Patch by Regions 2020-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Transdermal Patch by Types
3.2 Sales Value of Transdermal Patch by Types
3.3 Market Forecast of Transdermal Patch by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Transdermal Patch by Downstream Industry
4.2 Global Market Forecast of Transdermal Patch by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Transdermal Patch Market Status by Countries
5.1.1 North America Transdermal Patch Sales by Countries (2015-2019)
5.1.2 North America Transdermal Patch Revenue by Countries (2015-2019)
5.1.3 United States Transdermal Patch Market Status (2015-2019)
5.1.4 Canada Transdermal Patch Market Status (2015-2019)
5.1.5 Mexico Transdermal Patch Market Status (2015-2019)
5.2 North America Transdermal Patch Market Status by Manufacturers
5.3 North America Transdermal Patch Market Status by Type (2015-2019)
5.3.1 North America Transdermal Patch Sales by Type (2015-2019)
5.3.2 North America Transdermal Patch Revenue by Type (2015-2019)
5.4 North America Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Transdermal Patch Market Status by Countries
6.1.1 Europe Transdermal Patch Sales by Countries (2015-2019)
6.1.2 Europe Transdermal Patch Revenue by Countries (2015-2019)
6.1.3 Germany Transdermal Patch Market Status (2015-2019)
6.1.4 UK Transdermal Patch Market Status (2015-2019)
6.1.5 France Transdermal Patch Market Status (2015-2019)
6.1.6 Italy Transdermal Patch Market Status (2015-2019)
6.1.7 Russia Transdermal Patch Market Status (2015-2019)
6.1.8 Spain Transdermal Patch Market Status (2015-2019)
6.1.9 Benelux Transdermal Patch Market Status (2015-2019)
6.2 Europe Transdermal Patch Market Status by Manufacturers
6.3 Europe Transdermal Patch Market Status by Type (2015-2019)
6.3.1 Europe Transdermal Patch Sales by Type (2015-2019)
6.3.2 Europe Transdermal Patch Revenue by Type (2015-2019)
6.4 Europe Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Transdermal Patch Market Status by Countries
7.1.1 Asia Pacific Transdermal Patch Sales by Countries (2015-2019)
7.1.2 Asia Pacific Transdermal Patch Revenue by Countries (2015-2019)
7.1.3 China Transdermal Patch Market Status (2015-2019)
7.1.4 Japan Transdermal Patch Market Status (2015-2019)
7.1.5 India Transdermal Patch Market Status (2015-2019)
7.1.6 Southeast Asia Transdermal Patch Market Status (2015-2019)
7.1.7 Australia Transdermal Patch Market Status (2015-2019)
7.2 Asia Pacific Transdermal Patch Market Status by Manufacturers
7.3 Asia Pacific Transdermal Patch Market Status by Type (2015-2019)
7.3.1 Asia Pacific Transdermal Patch Sales by Type (2015-2019)
7.3.2 Asia Pacific Transdermal Patch Revenue by Type (2015-2019)
7.4 Asia Pacific Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Transdermal Patch Market Status by Countries
8.1.1 Latin America Transdermal Patch Sales by Countries (2015-2019)
8.1.2 Latin America Transdermal Patch Revenue by Countries (2015-2019)
8.1.3 Brazil Transdermal Patch Market Status (2015-2019)
8.1.4 Argentina Transdermal Patch Market Status (2015-2019)
8.1.5 Colombia Transdermal Patch Market Status (2015-2019)
8.2 Latin America Transdermal Patch Market Status by Manufacturers
8.3 Latin America Transdermal Patch Market Status by Type (2015-2019)
8.3.1 Latin America Transdermal Patch Sales by Type (2015-2019)
8.3.2 Latin America Transdermal Patch Revenue by Type (2015-2019)
8.4 Latin America Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Transdermal Patch Market Status by Countries
9.1.1 Middle East and Africa Transdermal Patch Sales by Countries (2015-2019)
9.1.2 Middle East and Africa Transdermal Patch Revenue by Countries (2015-2019)
9.1.3 Middle East Transdermal Patch Market Status (2015-2019)
9.1.4 Africa Transdermal Patch Market Status (2015-2019)
9.2 Middle East and Africa Transdermal Patch Market Status by Manufacturers
9.3 Middle East and Africa Transdermal Patch Market Status by Type (2015-2019)
9.3.1 Middle East and Africa Transdermal Patch Sales by Type (2015-2019)
9.3.2 Middle East and Africa Transdermal Patch Revenue by Type (2015-2019)
9.4 Middle East and Africa Transdermal Patch Market Status by Downstream Industry (2015-2019)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL PATCH
10.1 Global Economy Situation and Trend Overview
10.2 Transdermal Patch Downstream Industry Situation and Trend Overview
CHAPTER 11 TRANSDERMAL PATCH MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Transdermal Patch by Major Manufacturers
11.2 Production Value of Transdermal Patch by Major Manufacturers
11.3 Basic Information of Transdermal Patch by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Transdermal Patch Major Manufacturer
11.3.2 Employees and Revenue Level of Transdermal Patch Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 TRANSDERMAL PATCH MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Hisamitsu Pharmaceutical
12.1.1 Company profile
12.1.2 Representative Transdermal Patch Product
12.1.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
12.2 Gr?nenthal
12.2.1 Company profile
12.2.2 Representative Transdermal Patch Product
12.2.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Gr?nenthal
12.3 UCB Pharma
12.3.1 Company profile
12.3.2 Representative Transdermal Patch Product
12.3.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of UCB Pharma
12.4 Johnson & Johnson
12.4.1 Company profile
12.4.2 Representative Transdermal Patch Product
12.4.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.5 Nitto Denko
12.5.1 Company profile
12.5.2 Representative Transdermal Patch Product
12.5.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Nitto Denko
12.6 Novartis
12.6.1 Company profile
12.6.2 Representative Transdermal Patch Product
12.6.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Novartis
12.7 GSK
12.7.1 Company profile
12.7.2 Representative Transdermal Patch Product
12.7.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of GSK
12.8 Teva Pharmaceutical
12.8.1 Company profile
12.8.2 Representative Transdermal Patch Product
12.8.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
12.9 Mylan
12.9.1 Company profile
12.9.2 Representative Transdermal Patch Product
12.9.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mylan
12.10 IBSA Group
12.10.1 Company profile
12.10.2 Representative Transdermal Patch Product
12.10.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of IBSA Group
12.11 Bayer
12.11.1 Company profile
12.11.2 Representative Transdermal Patch Product
12.11.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Bayer
12.12 Beijing Tide Pharmaceutical
12.12.1 Company profile
12.12.2 Representative Transdermal Patch Product
12.12.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Beijing Tide Pharmaceutical
12.13 Luye Pharma Group
12.13.1 Company profile
12.13.2 Representative Transdermal Patch Product
12.13.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Luye Pharma Group
12.14 Mundipharma
12.14.1 Company profile
12.14.2 Representative Transdermal Patch Product
12.14.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mundipharma
12.15 Dr Reddy’s Laboratories
12.15.1 Company profile
12.15.2 Representative Transdermal Patch Product
12.15.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Dr Reddy’s Laboratories
12.16 Pfizer
12.17 Endo International
12.18 Chattem
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL PATCH
13.1 Industry Chain of Transdermal Patch
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL PATCH
14.1 Cost Structure Analysis of Transdermal Patch
14.2 Raw Materials Cost Analysis of Transdermal Patch
14.3 Labor Cost Analysis of Transdermal Patch
14.4 Manufacturing Expenses Analysis of Transdermal Patch
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
